Nitric oxide and angiogenesis.
Cooke
John P
JP
Losordo
Douglas W
DW
D020533:Angiogenesis Inhibitors / Q000096:biosynthesis; D043168:Angiostatins; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D001161:Arteriosclerosis / Q000209:etiology; D003326:Coronary Circulation; D004285:Dogs; D004730:Endothelium, Vascular / Q000378:metabolism; D020782:Matrix Metalloproteinases / Q000378:metabolism; D017202:Myocardial Ischemia / Q000097:blood / Q000378:metabolism; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology; D018919:Neovascularization, Physiologic; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D010446:Peptide Fragments / Q000096:biosynthesis; D010958:Plasminogen / Q000096:biosynthesis
D020533:Angiogenesis Inhibitors; D010446:Peptide Fragments; D009569:Nitric Oxide; C018524:N,N-dimethylarginine; D043168:Angiostatins; D010958:Plasminogen; D001120:Arginine; D019001:Nitric Oxide Synthase; D020782:Matrix Metalloproteinases; D019331:NG-Nitroarginine Methyl Ester